{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:26:04Z","timestamp":1791296764573,"version":"4.1.0"},"reference-count":233,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0002832","type":"journal-article","created":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T20:40:18Z","timestamp":1398976818000},"page":"e2832","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":80,"title":["Species-Directed Therapy for Leishmaniasis in Returning Travellers: A Comprehensive Guide"],"prefix":"10.1371","volume":"8","author":[{"given":"Caspar J.","family":"Hodiamont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet A.","family":"Kager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldert","family":"Bart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry J. C.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter P. A. M.","family":"van Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjalling","family":"Leenstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le","family":"van Vugt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P.","family":"Grobusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"van Gool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,5,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1469-0691.2004.01046.x","article-title":"Cutaneous leishmaniasis: an increasing threat for travellers","volume":"11","author":"S Antinori","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clindermatol.2006.05.008","article-title":"Cutaneous leishmaniasis","volume":"25","author":"MS Bailey","year":"2007","journal-title":"Clin Dermatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/clinids\/20.3.542","article-title":"Dermatoses associated with travel to tropical countries: a prospective study of the diagnosis and management of 269 patients presenting to a tropical disease unit","volume":"20","author":"E Caumes","year":"1995","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-4632.2004.01991.x","article-title":"Localized cutaneous leishmaniasis imported into Paris: a review of 39 cases","volume":"43","author":"L El Hajj","year":"2004","journal-title":"Int J Dermatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0035-9203(03)90084-8","article-title":"New World cutaneous leishmaniasis in returned travellers: treatment failures using intravenous sodium stibogluconate","volume":"97","author":"SD Lawn","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"20544","DOI":"10.2807\/1560-7917.ES2013.18.30.20544","article-title":"Imported leishmaniasis in the Netherlands from 2005 to 2012: epidemiology, diagnostic techniques and sequence-based species typing from 195 patients","volume":"18","author":"A Bart","year":"2013","journal-title":"Euro Surveill"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3201\/eid1210.060076","article-title":"Zoonotic cutaneous leishmaniasis, Afghanistan","volume":"12","author":"MK Faulde","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2133.1993.tb00149.x","article-title":"Cutaneous leishmaniasis in British troops from Belize","volume":"128","author":"NC Hepburn","year":"1993","journal-title":"Br J Dermatol"},{"key":"ref9","first-page":"35","article-title":"[Management of American cutaneous leishmaniasis. Outcome apropos of 326 cases treated with high-dose pentamidine isethionate]","volume":"63","author":"E Lightburn","year":"2003","journal-title":"Med Trop (Mars)"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.4269\/ajtmh.2010.10-0143","article-title":"Cutaneous leishmaniasis (<italic>Leishmania major<\/italic> infection) in Dutch troops deployed in northern Afghanistan: epidemiology, clinical aspects, and treatment","volume":"83","author":"PP van Thiel","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1086\/425747","article-title":"Old world leishmaniasis: an emerging infection among deployed US military and civilian workers","volume":"39","author":"PJ Weina","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref12","first-page":"353","article-title":"Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran","volume":"81","author":"A Asilian","year":"2003","journal-title":"Bull World Health Organ"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4269\/ajtmh.1995.53.162","article-title":"A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment","volume":"53","author":"A Ben Salah","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0738-081X(96)00058-2","article-title":"Cutaneous leishmaniasis: clinical aspect","volume":"14","author":"Y Dowlati","year":"1996","journal-title":"Clin Dermatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/infdis\/165.3.518","article-title":"The natural history of cutaneous leishmaniasis in Guatemala","volume":"165","author":"BL Herwaldt","year":"1992","journal-title":"J Infect Dis"},{"key":"ref16","first-page":"1","article-title":"Control of the leishmaniases. Report of a the WHO Expert Committee on the Control of Leishmaniases","volume":"949","year":"2010","journal-title":"World Health Organ Tech Rep Ser"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1708-8305.2008.00286.x","article-title":"Treatment of cutaneous leishmaniasis in travelers 2009","volume":"16","author":"JA Blum","year":"2009","journal-title":"J Travel Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0732-8893(03)00040-3","article-title":"Diagnostic genotyping of Old and New World <italic>Leishmania<\/italic> species by PCR-RFLP","volume":"46","author":"J Marfurt","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"20543","DOI":"10.2807\/1560-7917.ES2013.18.30.20543","article-title":"Heat-shock protein 70 gene sequencing for <italic>Leishmania<\/italic> species typing in European tropical infectious disease clinics","volume":"18","author":"G Van der Auwera","year":"2013","journal-title":"Euro Surveill"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"SL Croft","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"ref21","first-page":"CD005067","article-title":"Interventions for Old World cutaneous leishmaniasis","author":"U Gonzalez","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"ref22","first-page":"CD004834","article-title":"Interventions for American cutaneous and mucocutaneous leishmaniasis","author":"U Gonzalez","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/jac\/dkh058","article-title":"Treatment of cutaneous leishmaniasis among travellers","volume":"53","author":"J Blum","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1610-0379.2011.07820.x","article-title":"[Diagnosis and therapy of cutaneous and mucocutaneous Leishmaniasis in Germany]","volume":"9 Suppl 8","author":"G Boecken","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref25","first-page":"173","article-title":"[Therapy of leishmaniasis in France: consensus on proposed guidelines]","volume":"40","author":"PA Buffet","year":"2011","journal-title":"Presse Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1586\/eri.10.19","article-title":"Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis","volume":"8","author":"H Goto","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaad.2009.06.088","article-title":"New World cutaneous leishmaniasis: updated review of current and future diagnosis and treatment","volume":"63","author":"P Mitropoulos","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1473-3099(06)70492-3","article-title":"New world cutaneous leishmaniasis in travellers","volume":"6","author":"E Schwartz","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4269\/ajtmh.2006.74.76","article-title":"Evaluation of a new recombinant K39 rapid diagnostic test for Sudanese visceral leishmaniasis","volume":"74","author":"K Ritmeijer","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4269\/ajtmh.2005.72.421","article-title":"Short report: efficacy of pentavalent antimony for treatment of colombian cutaneous leishmaniasis","volume":"72","author":"J Soto","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-4362.1991.tb04878.x","article-title":"Cutaneous leishmaniasis in Kuwait. Clinical experience with itraconazole","volume":"30","author":"AS al-Fouzan","year":"1991","journal-title":"Int J Dermatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa011882","article-title":"Fluconazole for the treatment of cutaneous leishmaniasis caused by <italic>Leishmania major<\/italic>","volume":"346","author":"AA Alrajhi","year":"2002","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1365-4362.1995.tb00622.x","article-title":"Ketoconazole in the treatment of cutaneous leishmaniasis in Kuwait","volume":"34","author":"QA Alsaleh","year":"1995","journal-title":"Int J Dermatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0020-7519(96)00128-2","article-title":"Itraconazole and leishmaniasis: a randomised double-blind trial in cutaneous disease","volume":"26","author":"J Dogra","year":"1996","journal-title":"Int J Parasitol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archderm.1996.03890310070009","article-title":"Treatment of cutaneous leishmaniasis with itraconazole. Randomized double-blind study","volume":"132","author":"AZ Momeni","year":"1996","journal-title":"Arch Dermatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4269\/ajtmh.2007.76.48","article-title":"Healing of Old World cutaneous leishmaniasis in travelers treated with fluconazole: drug effect or spontaneous evolution","volume":"76","author":"G Morizot","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1468-3083.2004.01133.x","article-title":"A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis","volume":"19","author":"M Nassiri-Kashani","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/09546630152607899","article-title":"Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis","volume":"12","author":"R Salmanpour","year":"2001","journal-title":"J Dermatolog Treat"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00417211","article-title":"Efficacy of ketoconazole in cutaneous leishmaniasis","volume":"275","author":"L Weinrauch","year":"1983","journal-title":"Arch Dermatol Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/cid\/cir496","article-title":"High-dose oral fluconazole therapy effective for cutaneous leishmaniasis due to <italic>Leishmania (Vianna) braziliensis<\/italic>","volume":"53","author":"AQ Sousa","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaad.2010.04.014","article-title":"Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous <italic>leishmania major<\/italic> infection: a randomized clinical trial","volume":"64","author":"M Emad","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4269\/ajtmh.2009.80.172","article-title":"Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children","volume":"80","author":"P Layegh","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-4362.1986.tb03461.x","article-title":"Cryotherapy in acute cutaneous leishmaniasis","volume":"25","author":"V Leibovici","year":"1986","journal-title":"Int J Dermatol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jaad.2007.12.032","article-title":"Efficacy of a weekly cryotherapy regimen to treat <italic>Leishmania major<\/italic> cutaneous leishmaniasis","volume":"58","author":"IM Mosleh","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-4632.2004.02002.x","article-title":"Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis","volume":"43","author":"A Asilian","year":"2004","journal-title":"Int J Dermatol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1365-4632.2006.02822.x","article-title":"Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis","volume":"45","author":"R Salmanpour","year":"2006","journal-title":"Int J Dermatol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1645\/GE-185R","article-title":"Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience in Turkey","volume":"90","author":"S Uzun","year":"2004","journal-title":"J Parasitol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/cid\/cit049","article-title":"Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis","volume":"56","author":"J Soto","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-4362.1990.tb03759.x","article-title":"Cutaneous leishmaniasis. Treatment with combined cryotherapy and intralesional stibogluconate injection","volume":"29","author":"MA el Darouti","year":"1990","journal-title":"Int J Dermatol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1371\/journal.pntd.0000381","article-title":"Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trials","volume":"3","author":"DH Kim","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJMoa1202657","article-title":"Topical paromomycin with or without gentamicin for cutaneous leishmaniasis","volume":"368","author":"A Ben Salah","year":"2013","journal-title":"N Engl J Med"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4269\/ajtmh.12-0736","article-title":"Randomized, double-blinded, phase 2 trial of WR 279,396 (paromomycin and gentamicin) for cutaneous leishmaniasis in Panama","volume":"89","author":"N Sosa","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control","volume":"5","author":"F Chappuis","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4269\/ajtmh.12-0784","article-title":"Clinical and epidemiologic profile of cutaneous leishmaniasis in Colombian children: considerations for local treatment","volume":"89","author":"VM Blanco","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0140-6736(10)62237-4","article-title":"Combination therapy for visceral leishmaniasis","volume":"377","author":"J van Griensven","year":"2011","journal-title":"Lancet"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/00002030-199906180-00009","article-title":"Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-<italic>Leishmania<\/italic> Study Group","volume":"13","author":"F Laguna","year":"1999","journal-title":"AIDS"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: the second 10 years","volume":"21","author":"J Alvar","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa0903627","article-title":"Single-dose liposomal amphotericin B for visceral leishmaniasis in India","volume":"362","author":"S Sundar","year":"2010","journal-title":"N Engl J Med"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0924-8579(00)00312-5","article-title":"A single high dose treatment of kala-azar with Ambisome (amphotericin B lipid complex): a pilot study","volume":"17","author":"CP Thakur","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1046\/j.1365-3156.2003.01088.x","article-title":"Visceral leishmaniasis and HIV in Tigray, Ethiopia","volume":"8","author":"S Lyons","year":"2003","journal-title":"Trop Med Int Health"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0035-9203(01)90110-5","article-title":"Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome","volume":"95","author":"K Ritmeijer","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1086\/367843","article-title":"Two doses of a lipid formulation of amphotericin B for the treatment of Mediterranean visceral leishmaniasis","volume":"36","author":"V Syriopoulou","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref63","first-page":"181","article-title":"[Mediterranean visceral leishmaniasis]","volume":"195","author":"P Marty","year":"2011","journal-title":"Bull Acad Natl Med"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"e628","DOI":"10.1371\/journal.pntd.0000628","article-title":"A randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous <italic>Leishmania major<\/italic> infection","volume":"4","author":"NE Aronson","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1086\/428736","article-title":"Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by <italic>Leishmania tropica<\/italic> in Kabul, Afghanistan: a randomized, controlled trial","volume":"40","author":"R Reithinger","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.actatropica.2007.05.005","article-title":"Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran","volume":"103","author":"M Mohebali","year":"2007","journal-title":"Acta Trop"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1086\/648726","article-title":"Miltefosine treatment of <italic>Leishmania major<\/italic> infection: an observational study involving Dutch military personnel returning from northern Afghanistan","volume":"50","author":"PP van Thiel","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.trstmh.2012.02.006","article-title":"Treatment response of cutaneous leishmaniasis due to <italic>Leishmania aethiopica<\/italic> to cryotherapy and generic sodium stibogluconate from patients in Silti, Ethiopia","volume":"106","author":"E Negera","year":"2012","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4269\/ajtmh.1997.57.309","article-title":"Treatment of cutaneous leishmaniasis with localized current field (radio frequency) in Tabasco, Mexico","volume":"57","author":"O Velasco-Castrejon","year":"1997","journal-title":"Am J Trop Med Hyg"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0001-706X(01)00197-8","article-title":"Sensitivities of <italic>Leishmania<\/italic> species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B","volume":"81","author":"P Escobar","year":"2002","journal-title":"Acta Trop"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for new world cutaneous leishmaniasis","volume":"38","author":"J Soto","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1590\/S0365-05962011000600005","article-title":"A randomized clinical trial comparing meglumine antimoniate, pentamidine and amphotericin B for the treatment of cutaneous leishmaniasis by <italic>Leishmania guyanensis<\/italic>","volume":"86","author":"LO Neves","year":"2011","journal-title":"An Bras Dermatol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"e980","DOI":"10.1371\/journal.pntd.0000980","article-title":"Mucosal Leishmaniasis caused by <italic>Leishmania (Viannia) braziliensis<\/italic> and <italic>Leishmania (Viannia) guyanensis<\/italic> in the Brazilian Amazon","volume":"5","author":"JA Guerra","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3201\/eid1309.061446","article-title":"Recurrent American cutaneous leishmaniasis","volume":"13","author":"JP Gangneux","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/0035-9203(89)90375-1","article-title":"Epidemiological aspects of human cutaneous leishmaniasis in French Guiana","volume":"83","author":"JP Dedet","year":"1989","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1179\/000349802125002293","article-title":"Human cutaneous leishmaniasis caused by <italic>Leishmania naiffi<\/italic> is wide-spread in South America","volume":"96","author":"F Pratlong","year":"2002","journal-title":"Ann Trop Med Parasitol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4269\/ajtmh.2008.78.210","article-title":"Efficacy of miltefosine for Bolivian cutaneous leishmaniasis","volume":"78","author":"J Soto","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1468-3083.2009.03238.x","article-title":"Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil","volume":"23","author":"VS Amato","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0035-9203(97)90404-1","article-title":"Mucosal leishmaniasis unresponsive to glucantime therapy successfully treated with AmBisome","volume":"91","author":"R Nonata","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1086\/510588","article-title":"Treatment of Bolivian mucosal leishmaniasis with miltefosine","volume":"44","author":"J Soto","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4269\/ajtmh.2001.65.87","article-title":"Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony","volume":"65","author":"HA Lessa","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1086\/511643","article-title":"Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis","volume":"44","author":"PR Machado","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.pt.2010.06.013","article-title":"Is it time to revise the nomenclature of <italic>Leishmania<\/italic>","volume":"26","author":"G Schonian","year":"2010","journal-title":"Trends Parasitol"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"838","DOI":"10.4269\/ajtmh.1999.61.838","article-title":"Genetic analysis of leishmania parasites in Ecuador: are <italic>Leishmania (Viannia) panamensis<\/italic> and <italic>Leishmania (V.) guyanensis<\/italic> distinct taxa","volume":"61","author":"AL Ba\u00f1uls","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.meegid.2009.11.007","article-title":"Phylogeny of <italic>Leishmania<\/italic> species based on the heat-shock protein 70 gene","volume":"10","author":"J Fraga","year":"2010","journal-title":"Infect Genet Evol"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1992.46.296","article-title":"Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies","volume":"46","author":"BL Herwaldt","year":"1992","journal-title":"Am J Trop Med Hyg"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"e2130","DOI":"10.1371\/journal.pntd.0002130","article-title":"Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis","volume":"7","author":"P Olliaro","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref88","first-page":"20538","article-title":"LeishMan: harmonising diagnostic and clinical management of leishmaniasis in Europe","volume":"18","author":"J Blum","year":"2013","journal-title":"Euro Surveill"},{"key":"ref89","first-page":"25","article-title":"Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries","volume":"76","author":"JD Berman","year":"1998","journal-title":"Bull World Health Organ"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0035-9203(99)90036-6","article-title":"Dose-ranging studies on liposomal amphotericin B (L-AMP-LRC-1) in the treatment of visceral leishmaniasis","volume":"93","author":"PV Bodhe","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref91","first-page":"117","article-title":"A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India","volume":"5","author":"VN Das","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4269\/ajtmh.1995.52.536","article-title":"Use of amphotericin B in drug-resistant cases of visceral leishmaniasis in north Bihar, India","volume":"52","author":"TK Jha","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/0140-6736(91)90268-T","article-title":"Amphotericin B for second-line treatment of Indian kala-azar","volume":"337","author":"M Mishra","year":"1991","journal-title":"Lancet"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/0140-6736(92)92952-C","article-title":"Amphotericin versus pentamidine in antimony-unresponsive kala-azar","volume":"340","author":"M Mishra","year":"1992","journal-title":"Lancet"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0140-6736(94)90406-5","article-title":"Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar","volume":"344","author":"M Mishra","year":"1994","journal-title":"Lancet"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/tropej\/fmp132","article-title":"Amphotericin B therapy in children with visceral leishmaniasis: daily vs. alternate day, a randomized trial","volume":"56","author":"UK Singh","year":"2010","journal-title":"J Trop Pediatr"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4269\/ajtmh.2010.10-0156","article-title":"Effectiveness and safety of liposomal amphotericin B for visceral leishmaniasis under routine program conditions in Bihar, India","volume":"83","author":"PK Sinha","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1086\/500138","article-title":"Amphotericin B colloidal dispersion for the treatment of Indian visceral leishmaniasis","volume":"42","author":"S Sundar","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/380971","article-title":"Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations","volume":"38","author":"S Sundar","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/520665","article-title":"Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions","volume":"45","author":"S Sundar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(10)62050-8","article-title":"Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial","volume":"377","author":"S Sundar","year":"2011","journal-title":"Lancet"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/infdis\/173.3.762","article-title":"Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex","volume":"173","author":"S Sundar","year":"1996","journal-title":"J Infect Dis"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1056\/NEJMoa066536","article-title":"Injectable paromomycin for Visceral leishmaniasis in India","volume":"356","author":"S Sundar","year":"2007","journal-title":"N Engl J Med"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4269\/ajtmh.2002.66.143","article-title":"Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study","volume":"66","author":"S Sundar","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/591972","article-title":"New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine","volume":"47","author":"S Sundar","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","article-title":"Oral miltefosine for Indian visceral leishmaniasis","volume":"347","author":"S Sundar","year":"2002","journal-title":"N Engl J Med"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"700","DOI":"10.4269\/ajtmh.2009.80.700","article-title":"Safety and efficacy of high-dose infusions of a preformed amphotericin B fat emulsion for treatment of Indian visceral leishmaniasis","volume":"80","author":"S Sundar","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0035-9203(00)90277-3","article-title":"Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis","volume":"94","author":"S Sundar","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-127-2-199707150-00007","article-title":"Short-course, low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony","volume":"127","author":"S Sundar","year":"1997","journal-title":"Ann Intern Med"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/377542","article-title":"Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study","volume":"37","author":"S Sundar","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/00034983.1998.11813337","article-title":"Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B-lipid complex","volume":"92","author":"S Sundar","year":"1998","journal-title":"Ann Trop Med Parasitol"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/bmj.323.7310.419","article-title":"Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial","volume":"323","author":"S Sundar","year":"2001","journal-title":"BMJ"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1179\/000349804225003154","article-title":"A comparative evaluation of amphotericin B and sodium antimony gluconate, as first-line drugs in the treatment of Indian visceral leishmaniasis","volume":"98","author":"CP Thakur","year":"2004","journal-title":"Ann Trop Med Parasitol"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0035-9203(99)90037-8","article-title":"Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases","volume":"93","author":"CP Thakur","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/00034983.1994.11812878","article-title":"Are incremental doses of amphotericin B required for the treatment of visceral leishmaniasis","volume":"88","author":"CP Thakur","year":"1994","journal-title":"Ann Trop Med Parasitol"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/0035-9203(94)90236-4","article-title":"Comparison of glucose versus fat emulsion in the preparation of amphotericin B for use in kala-azar","volume":"88","author":"CP Thakur","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref117","first-page":"259","article-title":"Comparison of regimens of amphotericin B deoxycholate in kala-azar","volume":"103","author":"CP Thakur","year":"1996","journal-title":"Indian J Med Res"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0035-9203(96)90271-0","article-title":"Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study","volume":"90","author":"CP Thakur","year":"1996","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref119","first-page":"582","article-title":"Comparison of treatment regimens of kala-azar based on culture &amp; sensitivity of amastigotes to sodium antimony gluconate","volume":"127","author":"CP Thakur","year":"2008","journal-title":"Indian J Med Res"},{"key":"ref120","first-page":"931","article-title":"Daily versus alternate-day regimen of amphotericin B in the treatment of kala-azar: a randomized comparison","volume":"72","author":"CP Thakur","year":"1994","journal-title":"Bull World Health Organ"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF02860503","article-title":"Efficacy of amphotericin B in multi-drug resistant kala-azar in children in first decade of life","volume":"60","author":"CP Thakur","year":"1993","journal-title":"Indian J Pediatr"},{"key":"ref122","first-page":"166","article-title":"Epidemiological, clinical &amp; pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India","volume":"120","author":"CP Thakur","year":"2004","journal-title":"Indian J Med Res"},{"key":"ref123","first-page":"170","article-title":"Evaluation of amphotericin B as a first line drug in comparison to sodium stibogluconate in the treatment of fresh cases of kala-azar","volume":"97","author":"CP Thakur","year":"1993","journal-title":"Indian J Med Res"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1086\/380638","article-title":"Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India","volume":"38","author":"SK Bhattacharya","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/519690","article-title":"Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis","volume":"196","author":"SK Bhattacharya","year":"2007","journal-title":"J Infect Dis"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJM199912093412403","article-title":"Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis","volume":"341","author":"TK Jha","year":"1999","journal-title":"N Engl J Med"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/01.inf.0000066877.72624.cb","article-title":"Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis","volume":"22","author":"S Sundar","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"ref128","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/00034983.1999.11813462","article-title":"Oral treatment of visceral leishmaniasis with miltefosine","volume":"93","author":"S Sundar","year":"1999","journal-title":"Ann Trop Med Parasitol"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1086\/318122","article-title":"Short-course of oral miltefosine for treatment of visceral leishmaniasis","volume":"31","author":"S Sundar","year":"2000","journal-title":"Clin Infect Dis"},{"key":"ref130","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0140-6736(98)04367-0","article-title":"Trial of oral miltefosine for visceral leishmaniasis","volume":"352","author":"S Sundar","year":"1998","journal-title":"Lancet"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.316.7139.1200","article-title":"Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India","volume":"316","author":"TK Jha","year":"1998","journal-title":"BMJ"},{"key":"ref132","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0035-9203(03)90167-2","article-title":"Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline","volume":"97","author":"S Rijal","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref133","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/infdis\/171.4.992","article-title":"Immunochemotherapy for a systemic intracellular infection: accelerated response using interferon-gamma in visceral leishmaniasis","volume":"171","author":"S Sundar","year":"1995","journal-title":"J Infect Dis"},{"key":"ref134","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/516526","article-title":"Response to interferon-gamma plus pentavalent antimony in Indian visceral leishmaniasis","volume":"176","author":"S Sundar","year":"1997","journal-title":"J Infect Dis"},{"key":"ref135","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic","volume":"31","author":"S Sundar","year":"2000","journal-title":"Clin Infect Dis"},{"key":"ref136","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/bmj.288.6421.895","article-title":"Comparison of regimens of treatment with sodium stibogluconate in kala-azar","volume":"288","author":"CP Thakur","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref137","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1136\/bmj.296.6636.1557","article-title":"Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study","volume":"296","author":"CP Thakur","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref138","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/00034983.1998.11813313","article-title":"Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases","volume":"92","author":"CP Thakur","year":"1998","journal-title":"Ann Trop Med Parasitol"},{"key":"ref139","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0035-9203(00)90131-7","article-title":"Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study","volume":"94","author":"CP Thakur","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref140","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0035-9203(00)90130-5","article-title":"A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis","volume":"94","author":"CP Thakur","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1179\/136485908X252142","article-title":"Safety and effectiveness of amphotericin B deoxycholate for the treatment of visceral leishmaniasis in Uganda","volume":"102","author":"Y Mueller","year":"2008","journal-title":"Ann Trop Med Parasitol"},{"key":"ref142","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/clinids\/21.1.188","article-title":"Liposomal amphotericin B (AmBisome) in the treatment of complicated kala-azar under field conditions","volume":"21","author":"J Seaman","year":"1995","journal-title":"Clin Infect Dis"},{"key":"ref143","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/505217","article-title":"A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection","volume":"43","author":"K Ritmeijer","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref144","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(83)92588-6","article-title":"Comparison of two dosage schedules of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya","volume":"1","author":"GM Anabwani","year":"1983","journal-title":"Lancet"},{"key":"ref145","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/infdis\/148.1.148","article-title":"A comparison of three dosage regimens of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya","volume":"148","author":"JD Chulay","year":"1983","journal-title":"J Infect Dis"},{"key":"ref146","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0035-9203(90)90263-E","article-title":"Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate","volume":"84","author":"CN Chunge","year":"1990","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref147","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1086\/381203","article-title":"Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan","volume":"38","author":"S Collin","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref148","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1365-3156.2010.02550.x","article-title":"Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co-infection in northwest Ethiopia","volume":"15","author":"Z Hurissa","year":"2010","journal-title":"Trop Med Int Health"},{"key":"ref149","first-page":"388","article-title":"Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya","volume":"79","author":"E Moore","year":"2001","journal-title":"Bull World Health Organ"},{"key":"ref150","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/infdis\/168.3.715","article-title":"Epidemic visceral leishmaniasis in Sudan: a randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone","volume":"168","author":"J Seaman","year":"1993","journal-title":"J Infect Dis"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"664","DOI":"10.7326\/0003-4819-124-7-199604010-00007","article-title":"Epidemic visceral leishmaniasis in southern Sudan: treatment of severely debilitated patients under wartime conditions and with limited resources","volume":"124","author":"J Seaman","year":"1996","journal-title":"Ann Intern Med"},{"key":"ref152","doi-asserted-by":"crossref","first-page":"666","DOI":"10.4269\/ajtmh.1993.48.666","article-title":"Immunochemotherapy for visceral leishmaniasis: a controlled pilot trial of antimony versus antimony plus interferon-gamma","volume":"48","author":"KE Squires","year":"1993","journal-title":"Am J Trop Med Hyg"},{"key":"ref153","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1365-3156.2000.00555.x","article-title":"A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan","volume":"5","author":"H Veeken","year":"2000","journal-title":"Trop Med Int Health"},{"key":"ref154","first-page":"75","article-title":"Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial","volume":"87","author":"R Davidson","year":"1994","journal-title":"Q J Med"},{"key":"ref155","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/clinids\/22.6.938","article-title":"Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome)","volume":"22","author":"RN Davidson","year":"1996","journal-title":"Clin Infect Dis"},{"key":"ref156","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0022-3476(97)70165-3","article-title":"Treatment of visceral leishmaniasis in children with liposomal amphotericin B","volume":"131","author":"L di Martino","year":"1997","journal-title":"J Pediatr"},{"key":"ref157","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3201\/eid0907.030023","article-title":"Leishmaniasis in Germany","volume":"9","author":"G Harms","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"ref158","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijantimicag.2004.09.011","article-title":"Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds","volume":"25","author":"DA Kafetzis","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"ref159","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3109\/09546630903287445","article-title":"Randomized, double-blind, comparative clinical trial on the efficacy and safety of intralesional sodium stibogluconate and intralesional 7% hypertonic sodium chloride against cutaneous leishmaniasis caused by <italic>L. donovani<\/italic>","volume":"21","author":"RR Ranawaka","year":"2010","journal-title":"J Dermatolog Treat"},{"key":"ref160","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1468-3083.2010.03781.x","article-title":"Efficacy of CO(2) laser for treatment of anthroponotic cutaneous leishmaniasis, compared with combination of cryotherapy and intralesional meglumine antimoniate","volume":"25","author":"S Shamsi Meymandi","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1365-2133.2010.09865.x","article-title":"Efficacy of short-duration (twice weekly) intralesional sodium stibogluconate in treatment of cutaneous Leishmaniasis in India","volume":"163","author":"RA Bumb","year":"2010","journal-title":"Br J Dermatol"},{"key":"ref162","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1185\/03007997909109438","article-title":"Evaluation of sodium stibogluconate in the treatment of cutaneous leishmaniasis in Syria","volume":"6","author":"S Ghosn","year":"1979","journal-title":"Curr Med Res Opin"},{"key":"ref163","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0035-9203(91)90026-U","article-title":"A randomized trial comparing a pentavalent antimonial drug and recombinant interferon-gamma in the local treatment of cutaneous leishmaniasis","volume":"85","author":"G Harms","year":"1991","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref164","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1365-4362.2002.01526.x","article-title":"Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis","volume":"41","author":"I Esfandiarpour","year":"2002","journal-title":"Int J Dermatol"},{"key":"ref165","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/archderm.142.12.1575","article-title":"Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial","volume":"142","author":"A Firooz","year":"2006","journal-title":"Arch Dermatol"},{"key":"ref166","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4269\/ajtmh.2011.10-0002","article-title":"Systemic meglumine antimoniate in acute cutaneous leishmaniasis: children versus adults","volume":"84","author":"P Layegh","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"ref167","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/00034983.1997.11813217","article-title":"Treatment of cutaneous leishmaniasis with antimony: intramuscular versus intralesional administration","volume":"91","author":"AM Alkhawajah","year":"1997","journal-title":"Ann Trop Med Parasitol"},{"key":"ref168","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1365-4632.2004.02597.x","article-title":"Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis","volume":"44","author":"Z Moosavi","year":"2005","journal-title":"Int J Dermatol"},{"key":"ref169","first-page":"85","article-title":"Comparison of topical paromomycin sulfate (twice\/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major","volume":"15","author":"B Shazad","year":"2005","journal-title":"Eur J Dermatol"},{"key":"ref170","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1468-3083.2009.03157.x","article-title":"Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate","volume":"23","author":"M Solomon","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/0035-9203(86)90176-8","article-title":"Failure of meglumine antimoniate to cure cutaneous lesions due to <italic>Leishmania major<\/italic> in Algeria","volume":"80","author":"S Belazzoug","year":"1986","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref172","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-4632.2009.04072.x","article-title":"Efficacy of glucantime in the treatment of Old World cutaneous leishmaniasis","volume":"48","author":"R Firdous","year":"2009","journal-title":"Int J Dermatol"},{"key":"ref173","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-4362.2002.01527.x","article-title":"Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate","volume":"41","author":"AZ Momeni","year":"2002","journal-title":"Int J Dermatol"},{"key":"ref174","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-4632.2006.02867.x","article-title":"Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis","volume":"45","author":"G Sadeghian","year":"2006","journal-title":"Int J Dermatol"},{"key":"ref175","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1179\/000349803225001373","article-title":"The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis","volume":"97","author":"A Asilian","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"ref176","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2230.2003.01169.x","article-title":"Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate","volume":"28","author":"G Faghihi","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"ref177","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1365-4362.1993.tb05044.x","article-title":"Intralesional treatment of cutaneous leishmaniasis with sodium stibogluconate antimony","volume":"32","author":"RM Faris","year":"1993","journal-title":"Int J Dermatol"},{"key":"ref178","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000078586","article-title":"Comparison of intralesionally injected zinc sulfate with meglumine antimoniate in the treatment of acute cutaneous leishmaniasis","volume":"209","author":"F Iraji","year":"2004","journal-title":"Dermatology"},{"key":"ref179","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1365-4362.1999.00769.x","article-title":"Weekly vs. fortnightly intralesional meglumine antimoniate in cutaneous leishmaniasis","volume":"38","author":"G Mujtaba","year":"1999","journal-title":"Int J Dermatol"},{"key":"ref180","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1472-6882-7-13","article-title":"Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis","volume":"7","author":"MA Nilforoushzadeh","year":"2007","journal-title":"BMC Complement Altern Med"},{"key":"ref181","first-page":"8","article-title":"A comparison between intralesional hypertonic sodium chloride solution and meglomine antimoniate in the treatment of cutaneous leishmaniasis","volume":"2","author":"G Sadeghian","year":"2006","journal-title":"Egyptian Dermatology Online Journal"},{"key":"ref182","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2230.2007.02405.x","article-title":"Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate","volume":"32","author":"G Sadeghian","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"ref183","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2133.1988.tb07100.x","article-title":"Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimony","volume":"119","author":"KE Sharquie","year":"1988","journal-title":"Br J Dermatol"},{"key":"ref184","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1346-8138.1995.tb03911.x","article-title":"A new intralesional therapy of cutaneous leishmaniasis with hypertonic sodium chloride solution","volume":"22","author":"KE Sharquie","year":"1995","journal-title":"J Dermatol"},{"key":"ref185","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2230.1997.tb01054.x","article-title":"A comparative controlled trial of intralesionally-administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis","volume":"22","author":"KE Sharquie","year":"1997","journal-title":"Clin Exp Dermatol"},{"key":"ref186","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1346-8138.1998.tb02387.x","article-title":"Treatment of cutaneous leishmaniasis by direct current electrotherapy: the Baghdadin device","volume":"25","author":"KE Sharquie","year":"1998","journal-title":"J Dermatol"},{"key":"ref187","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3923\/ijp.2006.633.636","article-title":"Comparative effect of topical trichloroacetic acid and intralesional meglumine antimoniate in the treatment of acute cutaneous leishmaniasis","volume":"2","author":"MA Nilforoushzadeh","year":"2006","journal-title":"Int J Pharm"},{"key":"ref188","first-page":"350","article-title":"Ultrasound-induced hyperthermia in the treatment of cutaneous leishmaniasis","volume":"40","author":"H Aram","year":"1987","journal-title":"Cutis"},{"key":"ref189","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-4632.2004.02349.x","article-title":"Evaluation of CO laser efficacy in the treatment of cutaneous leishmaniasis","volume":"43","author":"A Asilian","year":"2004","journal-title":"Int J Dermatol"},{"key":"ref190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5070\/D35ZB4V6KF","article-title":"Carbon dioxide laser for the treatment of lupoid cutaneous leishmaniasis (LCL): a case series of 24 patients","volume":"12","author":"A Asilian","year":"2006","journal-title":"Dermatol Online J"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4269\/ajtmh.2007.77.99","article-title":"Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis","volume":"77","author":"P Layegh","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"ref192","first-page":"287","article-title":"A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis","volume":"45","author":"MA Nilforoushzadeh","year":"2008","journal-title":"J Vector Borne Dis"},{"key":"ref193","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1046\/j.1365-4362.1999.00727.x","article-title":"A double-blind randomized clinical trial of a topical herbal extract (Z-HE) vs. systemic meglumine antimoniate for the treatment of cutaneous leishmaniasis in Iran","volume":"38","author":"F Zerehsaz","year":"1999","journal-title":"Int J Dermatol"},{"key":"ref194","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/clinids\/17.6.981","article-title":"Treatment of Brazilian kala-azar with a short course of amphocil (amphotericin B cholesterol dispersion)","volume":"17","author":"R Dietze","year":"1993","journal-title":"Clin Infect Dis"},{"key":"ref195","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0035-9203(95)90557-X","article-title":"Treatment of kala-azar in Brazil with Amphocil (amphotericin B cholesterol dispersion) for 5 days","volume":"89","author":"R Dietze","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref196","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/infdis\/170.2.413","article-title":"Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasis","volume":"170","author":"R Badaro","year":"1994","journal-title":"J Infect Dis"},{"key":"ref197","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/infdis\/165.3.528","article-title":"Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala","volume":"165","author":"TR Navin","year":"1992","journal-title":"J Infect Dis"},{"key":"ref198","doi-asserted-by":"crossref","first-page":"960","DOI":"10.4269\/ajtmh.1999.61.960","article-title":"Response of cutaneous leishmaniasis (chiclero&apos;s ulcer) to treatment with meglumine antimoniate in Southeast Mexico","volume":"61","author":"A Vargas-Gonzalez","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"ref199","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0035-9203(91)90437-4","article-title":"Cutaneous leishmaniasis due to <italic>Leishmania (Leishmania) amazonensis<\/italic> in Amazonian Brazil, and the significance of a negative Montenegro skin-test in human infections","volume":"85","author":"FT Silveira","year":"1991","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref200","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.2005.72.133","article-title":"Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis","volume":"72","author":"EM Andersen","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1086\/518172","article-title":"Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis","volume":"44","author":"I Arevalo","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref202","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1086\/518041","article-title":"Influence of <italic>Leishmania (Viannia)<\/italic> species on the response to antimonial treatment in patients with American tegumentary leishmaniasis","volume":"195","author":"J Arevalo","year":"2007","journal-title":"J Infect Dis"},{"key":"ref203","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1590\/S0037-86821996000500007","article-title":"[Comparative study of meglumine antimoniate, pentamidine isethionate and aminosidine sulfate in the treatment of primary skin lesions caused by <italic>Leishmania (Viannia) braziliensis<\/italic>]","volume":"29","author":"D Correia","year":"1996","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref204","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/0035-9203(94)90237-2","article-title":"Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis","volume":"88","author":"NC Hepburn","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref205","doi-asserted-by":"crossref","first-page":"640","DOI":"10.4269\/ajtmh.2007.77.640","article-title":"A randomized clinical trial comparing oral azithromycin and meglumine antimoniate for the treatment of American cutaneous leishmaniasis caused by <italic>Leishmania (Viannia) braziliensis<\/italic>","volume":"77","author":"AJ Krolewiecki","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"ref206","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1086\/524042","article-title":"Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru","volume":"46","author":"A Llanos-Cuentas","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref207","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1365-4362.2002.01336.x","article-title":"Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed <italic>Leishmania (Leishmania) amazonensis<\/italic> vaccine plus antimonial","volume":"41","author":"J Machado-Pinto","year":"2002","journal-title":"Int J Dermatol"},{"key":"ref208","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1086\/429238","article-title":"Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru","volume":"40","author":"C Miranda-Verastegui","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref209","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4269\/ajtmh.1990.42.43","article-title":"Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala","volume":"42","author":"TR Navin","year":"1990","journal-title":"Am J Trop Med Hyg"},{"key":"ref210","doi-asserted-by":"crossref","first-page":"651","DOI":"10.4269\/ajtmh.1997.57.651","article-title":"A low-dose antimony treatment in 159 patients with American cutaneous leishmaniasis: extensive follow-up studies (up to 10 years)","volume":"57","author":"MP Oliveira-Neto","year":"1997","journal-title":"Am J Trop Med Hyg"},{"key":"ref211","first-page":"496","article-title":"Treatment of American cutaneous leishmaniasis: a comparison between low dosage (5 mg\/kg\/day) and high dosage (20 mg\/kg\/day) antimony regimens","volume":"45","author":"MP Oliveira-Neto","year":"1997","journal-title":"Pathol Biol (Paris)"},{"key":"ref212","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1590\/S0037-86822006000400001","article-title":"An alternative antimonial schedule to be used in cutaneous leishmaniasis when high doses of antimony are undesirable","volume":"39","author":"MP Oliveira-Neto","year":"2006","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref213","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4269\/ajtmh.2001.65.456","article-title":"Comparison of cutaneous leishmaniasis due to <italic>Leishmania (Viannia) braziliensis<\/italic> and <italic>L. (V.) guyanensis<\/italic> in Brazil: therapeutic response to meglumine antimoniate","volume":"65","author":"GA Romero","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"ref214","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/qjmed\/92.11.659","article-title":"Out-patient parenteral antimicrobial therapy\u2013a viable option for the management of cutaneous leishmaniasis","volume":"92","author":"RA Seaton","year":"1999","journal-title":"QJM"},{"key":"ref215","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4269\/ajtmh.2004.71.577","article-title":"Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis","volume":"71","author":"J Soto","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"ref216","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4269\/ajtmh.2010.10-0060","article-title":"Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis","volume":"83","author":"I Velez","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"ref217","doi-asserted-by":"crossref","first-page":"934","DOI":"10.7326\/0003-4819-113-12-934","article-title":"Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis","volume":"113","author":"ED Franke","year":"1990","journal-title":"Ann Intern Med"},{"key":"ref218","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4269\/ajtmh.1994.51.77","article-title":"Efficacy of 28-day and 40-day regimens of sodium stibogluconate (Pentostam) in the treatment of mucosal leishmaniasis","volume":"51","author":"ED Franke","year":"1994","journal-title":"Am J Trop Med Hyg"},{"key":"ref219","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1086\/513776","article-title":"Efficacy of sodium stibogluconate alone and in combination with allopurinol for treatment of mucocutaneous leishmaniasis","volume":"25","author":"A Llanos-Cuentas","year":"1997","journal-title":"Clin Infect Dis"},{"key":"ref220","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4269\/ajtmh.2007.76.1128","article-title":"Parenteral aminosidine is not effective for Peruvian mucocutaneous leishmaniasis","volume":"76","author":"A Llanos-Cuentas","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4269\/ajtmh.2009.81.387","article-title":"Efficacy of extended (six weeks) treatment with miltefosine for mucosal leishmaniasis in Bolivia","volume":"81","author":"J Soto","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"ref222","doi-asserted-by":"crossref","first-page":"889","DOI":"10.4269\/ajtmh.1998.59.889","article-title":"Lack of efficacy of mefloquine in the treatment of New World cutaneous leishmaniasis in Colombia","volume":"59","author":"EP Hendrickx","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"ref223","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJM199203123261105","article-title":"Allopurinol in the treatment of American cutaneous leishmaniasis","volume":"326","author":"S Martinez","year":"1992","journal-title":"N Engl J Med"},{"key":"ref224","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/clinids\/24.2.165","article-title":"Treatment of cutaneous leishmaniasis with allopurinol and stibogluconate","volume":"24","author":"S Martinez","year":"1997","journal-title":"Clin Infect Dis"},{"key":"ref225","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4269\/ajtmh.2001.64.187","article-title":"Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to <italic>Leishmania viannia<\/italic> species","volume":"64","author":"R Palacios","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"ref226","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/infdis\/jir816","article-title":"Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children","volume":"205","author":"LC Rubiano","year":"2012","journal-title":"J Infect Dis"},{"key":"ref227","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0002-9343(90)90292-L","article-title":"Efficacy of ketoconazole against <italic>Leishmania braziliensis panamensis<\/italic> cutaneous leishmaniasis","volume":"89","author":"RE Saenz","year":"1990","journal-title":"Am J Med"},{"key":"ref228","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1086\/341406","article-title":"A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel","volume":"35","author":"G Wortmann","year":"2002","journal-title":"Clin Infect Dis"},{"key":"ref229","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(87)93053-4","article-title":"Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis","volume":"2","author":"WR Ballou","year":"1987","journal-title":"Lancet"},{"key":"ref230","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1365-4362.2002.01633.x","article-title":"Pentamidine, the drug of choice for the treatment of cutaneous leishmaniasis in Surinam","volume":"41","author":"E Lai A Fat","year":"2002","journal-title":"Int J Dermatol"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/00034983.2001.11813645","article-title":"Influence of clinical presentation on the efficacy of a short course of pentamidine in the treatment of cutaneous leishmaniasis in French Guiana","volume":"95","author":"M Nacher","year":"2001","journal-title":"Ann Trop Med Parasitol"},{"key":"ref232","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1179\/136485906X105561","article-title":"Comparison between one and two injections of pentamidine isethionate, at 7 mg\/kg in each injection, in the treatment of cutaneous leishmaniasis in French Guiana","volume":"100","author":"M Roussel","year":"2006","journal-title":"Ann Trop Med Parasitol"},{"key":"ref233","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4269\/ajtmh.2011.10-0155","article-title":"Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis caused by <italic>Leishmania (Viannia) guyanensis<\/italic> in Manaus, Brazil","volume":"84","author":"A Chrusciak-Talhari","year":"2011","journal-title":"Am J Trop Med Hyg"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0002832","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T08:42:03Z","timestamp":1716712923000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0002832"}},"subtitle":[],"editor":[{"given":"Elodie","family":"Ghedin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,5,1]]},"references-count":233,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0002832","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,1]]}}}